Claudia Rutherford1, Daniel S J Costa2,3, Madeleine T King4,3, David P Smith5,6,7, Manish I Patel8. 1. Quality of Life Office, Psycho-oncology Co-operative Research Group, School of Psychology, University of Sydney, Camperdown, NSW, 2006, Australia. claudia.rutherford@sydney.edu.au. 2. Royal North Shore Hospital, Pain Management Research Institute, St Leonards, Sydney, NSW, Australia. 3. Central Clinical School, Sydney Medical School, University of Sydney, Camperdown, NSW, 2006, Australia. 4. Quality of Life Office, Psycho-oncology Co-operative Research Group, School of Psychology, University of Sydney, Camperdown, NSW, 2006, Australia. 5. Cancer Research Division, Cancer Council New South Wales, Kings Cross, NSW, Australia. 6. Sydney School of Public Health, University of Sydney, Camperdown, NSW, Australia. 7. Menzies Health Institute Queensland, Griffith University, Nathan, QLD, Australia. 8. Discipline of Surgery, Sydney Medical School, Westmead Hospital, University of Sydney and Department of Urology, Sydney, Australia.
Abstract
PURPOSE: Non-muscle invasive bladder cancer (NMIBC) is a chronic condition requiring repeated treatment and endoscopic examinations that can be life-long. In this context, health-related quality of life (HRQOL) is important to patients and managing clinicians, and integral to treatment recommendations for NMIBC. The aim of this study was to develop a conceptual framework of patient-reported NMIBC symptoms, treatment side effects, and HRQOL impacts from three sources: (1) literature, (2) patients and (3) treating clinicians. METHODS: First, we undertook a scoping literature review for studies reporting patient-reported outcomes associated with NMIBC. Outcomes were extracted and grouped conceptually. Then, we conducted semi-structured interviews with patients with NMIBC and treating clinicians. Patients were asked about symptoms and HRQOL impacts experienced from their NMIBC and treatments. Clinicians were asked about commonly reported outcomes, and outcomes they felt were important to assess clinically. Interviews were audio recorded, transcribed and content analysed. RESULTS: A total of 125 symptom- and functioning-related expressions from 18 studies, 26 patients and 20 clinicians were coded into three themes and 18 sub-themes. Patients commonly reported blood in urine and frequent urination. Clinicians considered BCG sepsis and flu-like symptoms important outcomes to assess during treatment for NMIBC. CONCLUSION: Our empirically derived conceptual framework identifies patient-reported outcomes that are important to people with NMIBC, provides the basis for the development of a new NMIBC-specific symptom index, and guides the design of a comprehensive PRO assessment plan for clinical practice in NMIBC and future clinical trials of treatments for NMIBC.
PURPOSE:Non-muscle invasive bladder cancer (NMIBC) is a chronic condition requiring repeated treatment and endoscopic examinations that can be life-long. In this context, health-related quality of life (HRQOL) is important to patients and managing clinicians, and integral to treatment recommendations for NMIBC. The aim of this study was to develop a conceptual framework of patient-reported NMIBC symptoms, treatment side effects, and HRQOL impacts from three sources: (1) literature, (2) patients and (3) treating clinicians. METHODS: First, we undertook a scoping literature review for studies reporting patient-reported outcomes associated with NMIBC. Outcomes were extracted and grouped conceptually. Then, we conducted semi-structured interviews with patients with NMIBC and treating clinicians. Patients were asked about symptoms and HRQOL impacts experienced from their NMIBC and treatments. Clinicians were asked about commonly reported outcomes, and outcomes they felt were important to assess clinically. Interviews were audio recorded, transcribed and content analysed. RESULTS: A total of 125 symptom- and functioning-related expressions from 18 studies, 26 patients and 20 clinicians were coded into three themes and 18 sub-themes. Patients commonly reported blood in urine and frequent urination. Clinicians considered BCG sepsis and flu-like symptoms important outcomes to assess during treatment for NMIBC. CONCLUSION: Our empirically derived conceptual framework identifies patient-reported outcomes that are important to people with NMIBC, provides the basis for the development of a new NMIBC-specific symptom index, and guides the design of a comprehensive PRO assessment plan for clinical practice in NMIBC and future clinical trials of treatments for NMIBC.
Entities:
Keywords:
Early bladder cancer; Non-muscle invasive bladder cancer; Patient-reported outcomes; Quality of life; Symptom burden; Treatment symptoms
Authors: A R Zlotta; J P van Vooren; K Huygen; A Drowart; M Decock; M Pirson; F Jurion; K Palfliet; O Denis; J Simon; C C Schulman Journal: Eur Urol Date: 2000-04 Impact factor: 20.096
Authors: Marko Babjuk; Willem Oosterlinck; Richard Sylvester; Eero Kaasinen; Andreas Böhle; Juan Palou-Redorta; Morgan Rouprêt Journal: Eur Urol Date: 2011-03-22 Impact factor: 20.096
Authors: Galina Velikova; Laura Booth; Adam B Smith; Paul M Brown; Pamela Lynch; Julia M Brown; Peter J Selby Journal: J Clin Oncol Date: 2004-02-15 Impact factor: 44.544
Authors: Margaret Rothman; Laurie Burke; Pennifer Erickson; Nancy Kline Leidy; Donald L Patrick; Charles D Petrie Journal: Value Health Date: 2009-09-25 Impact factor: 5.725
Authors: Claudia Rutherford; Manish I Patel; Margaret-Ann Tait; David P Smith; Daniel S J Costa; Shomik Sengupta; Madeleine T King Journal: Qual Life Res Date: 2020-09-22 Impact factor: 4.147
Authors: Ahrang Jung; Matthew E Nielsen; Jamie L Crandell; Mary H Palmer; Sophia K Smith; Ashley Leak Bryant; Deborah K Mayer Journal: BJU Int Date: 2019-09-25 Impact factor: 5.588
Authors: Claudia Rutherford; Madeleine T King; David P Smith; Daniel Sj Costa; Margaret-Ann Tait; Manish I Patel Journal: JMIR Res Protoc Date: 2017-11-08
Authors: Samantha J Mason; James W F Catto; Amy Downing; Sarah E Bottomley; Adam W Glaser; Penny Wright Journal: BJU Int Date: 2018-06-08 Impact factor: 5.588